ifampin + pyrazinamide for initial 2 months followed
by isoniazid + rifampin for another 4 months for the
following category of tubercular patients:
A. New sputum positive cases of pulmonary
tuberculosis
B. New sputum negative cases of pulmonary
tuberculosis
C. Sputum positive patients of pulmonary
tuberculosis who have interrupted treatment for more than 2 months
D. Tubercular meningitis patients
by isoniazid + rifampin for another 4 months for the
following category of tubercular patients:
A. New sputum positive cases of pulmonary
tuberculosis
B. New sputum negative cases of pulmonary
tuberculosis
C. Sputum positive patients of pulmonary
tuberculosis who have interrupted treatment for more than 2 months
D. Tubercular meningitis patients